Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based ...

With a market cap of $23.3 billion, Labcorp Holdings Inc. (LH) is a global life sciences and healthcare company. The North ...

LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds ...

Investors with an interest in Medical Services stocks have likely encountered both Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two companies is the best option for ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

A healthcare company is preparing to pay $35,000,000 to settle a class action lawsuit over a cybersecurity incident that ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

Collaboration leverages Olaris' scientific leadership in transplant diagnostics and Labcorp's scientific expertise and national scale to advance post-transplant monitoring. FRAMINGHAM, Mass.

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...

Detailed price information for Laboratory Corp of America (LH-N) from The Globe and Mail including charting and trades.